XBiotechXBIT 32 OCF Yield % is -59.36 as of Jun. 28, 2026. GuruFocus rates XBIT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 1,417 Biotechnology companies, XBiotech ranks worse than 85.82% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
XBiotech OCF Yield % Related Terms
XBiotech OCF Yield % Historical Data
* Premium members only.
The historical data trend for XBiotech's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, XBiotech's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XBiotech OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, XBiotech's OCF Yield % distribution charts can be found below:
* The bar in red indicates where XBiotech's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBiotech (XBIT) has a OCF Yield % of -59.36 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on XBiotech and its competitors. According to the industry distribution chart, XBiotech ranks #1216 out of 1417 companies in the Biotechnology industry, placing it in the top 85.8%.
Is XBiotech's OCF Yield % too high?
XBiotech's current OCF Yield % is -59.36. Based on the distribution chart, XBiotech ranks #1216 out of 1417 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, XBiotech has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does XBiotech's OCF Yield % compare to FLNA and MCRB?
According to the Biotechnology industry distribution chart, XBiotech ranks #1216 out of 1417 companies for OCF Yield %. This places XBiotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on XBiotech and its competitors. XBiotech's current OCF Yield % is -59.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XBiotech stock overvalued right now?
XBiotech (XBIT) has a current OCF Yield % of -59.36. The current OCF Yield % is -59.36. XBiotech's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For XBiotech (XBIT), the current OCF Yield % is -59.36 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
32GF Score
Get the complete analysis for XBIT
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBIT has been successfully added to your 
